Legal Representation
Attorney
                                            GABRIELLE S. ROTH
                                        USPTO Deadlines
                                Next Deadline
                            
                            
                                    
                                        
                                        1102 days remaining
                                    
                            
                        Section 8 & 9 (10-Year) Renewal Due (Based on registration date 2018-11-06)
                                    
                                    Due Date
                                
                                
                                    November 06, 2028
                                
                            
                                        
                                        Grace Period Ends
                                    
                                    
                                        May 06, 2029
                                    
                                Application History
50 events| Date | Code | Type | Description | Documents | 
|---|---|---|---|---|
| May 13, 2025 | NAS8 | E | NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED | Loading... | 
| May 13, 2025 | 8.OK | O | REGISTERED - SEC. 8 (6-YR) ACCEPTED | Loading... | 
| May 13, 2025 | APRE | A | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | Loading... | 
| Dec 23, 2024 | ES8R | I | TEAS SECTION 8 RECEIVED | Loading... | 
| Nov 6, 2023 | REM1 | E | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | Loading... | 
| Jan 30, 2020 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... | 
| Jan 30, 2020 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... | 
| Jan 21, 2020 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... | 
| Jan 21, 2020 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... | 
| Oct 16, 2019 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... | 
| Oct 16, 2019 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... | 
| Nov 6, 2018 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... | 
| Oct 2, 2018 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | Loading... | 
| Oct 1, 2018 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... | 
| Sep 18, 2018 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... | 
| Sep 18, 2018 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... | 
| Sep 17, 2018 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... | 
| Sep 17, 2018 | DPCC | D | DIVISIONAL PROCESSING COMPLETE | Loading... | 
| Sep 17, 2018 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... | 
| Aug 21, 2018 | IUAF | S | USE AMENDMENT FILED | Loading... | 
| Aug 21, 2018 | DRRR | I | DIVISIONAL REQUEST RECEIVED | Loading... | 
| Aug 21, 2018 | ERTD | I | TEAS REQUEST TO DIVIDE RECEIVED | Loading... | 
| Aug 21, 2018 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... | 
| Aug 20, 2018 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... | 
| Aug 20, 2018 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... | 
| Aug 20, 2018 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... | 
| Feb 27, 2018 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... | 
| Feb 20, 2018 | CHPB | I | POST PUBLICATION AMENDMENT - ENTERED | Loading... | 
| Feb 16, 2018 | APET | A | ASSIGNED TO PETITION STAFF | Loading... | 
| Feb 6, 2018 | EPPA | I | TEAS POST PUBLICATION AMENDMENT RECEIVED | Loading... | 
| Jan 2, 2018 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... | 
| Jan 2, 2018 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... | 
| Dec 13, 2017 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... | 
| Nov 26, 2017 | ALIE | A | ASSIGNED TO LIE | Loading... | 
| Nov 14, 2017 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... | 
| Nov 14, 2017 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... | 
| Nov 14, 2017 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... | 
| Nov 14, 2017 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... | 
| Nov 14, 2017 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... | 
| Nov 10, 2017 | ZZZX | Z | PREVIOUS ALLOWANCE COUNT WITHDRAWN | Loading... | 
| Nov 10, 2017 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... | 
| Nov 9, 2017 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... | 
| Nov 8, 2017 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... | 
| Nov 8, 2017 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... | 
| Jul 24, 2017 | GEAP | F | EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED | Loading... | 
| Jul 24, 2017 | GEAN | O | NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED | Loading... | 
| Jul 24, 2017 | CPEA | R | EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED | Loading... | 
| Jul 24, 2017 | EPEN | O | COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY | Loading... | 
| Jul 17, 2017 | DOCK | D | ASSIGNED TO EXAMINER | Loading... | 
| Jun 28, 2017 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... | 
Detailed Classifications
                                                Class 005
                                            
                                        Biological drugs for use in treating cancer [ , and autoimmunity ] ; therapeutic [ and medical diagnostic ] agents and preparations for use in therapies [ and diagnosis ] for cancer [ , and autoimmunity ] ; biochemicals, immunoglobulins and antigen-binding fragments for use in therapies [ and medical diagnosis ] for cancer [ , and autoimmunity ] ; therapeutic [ and diagnostic ] agents, preparations and substances for medical purposes for targeting application to immune system, cells [ , or genes ] ; immune modulators, immunoglobulin drug conjugates, immunotherapies and therapeutic [ and diagnostic ] agents, preparations and substances in the field of dysregulated proteolytic activity for medical purposes; immunotherapies and therapeutic [ and medical diagnostic ] agents, preparations and substances in the field of cancer [ , and autoimmunity ] for medical purposes
                                        
                                                    
                                                    First Use Anywhere: 
Jul 19, 2017                                                    
                                                
                                                
                                                    
                                                    First Use in Commerce: 
Jul 19, 2017                                                    
                                                
                                        Additional Information
                                                
                                                Design Mark
                                            
                                        The mark consists of three semi-circles aligned next to each other. The first semi-circle has its vertical opening facing to the right. It is separated by a narrow white space from the second semi-circle, whose vertical opening faces to the left. The third semi-circle's vertical opening faces to the right. The tips of the circular apexes of the second and third semi circles are adjoined to each other.
                                    
                                                
                                                Color Claim
                                            
                                        Color is not claimed as a feature of the mark.
                                    Classification
                                            
                                            International Classes
                                        
                                        
                                                    005